Regulus Therapeutics
RGLS
#9072
Rank
ยฃ74.94 M
Marketcap
ยฃ1.14
Share price
7.25%
Change (1 day)
-39.96%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ5.37 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are ยฃ5.37 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ7.5 M-32.36%
2022-12-31ยฃ11.09 M10.99%
2021-12-31ยฃ9.99 M17.71%
2020-12-31ยฃ8.49 M-49.52%
2019-12-31ยฃ16.82 M-36.77%
2018-12-31ยฃ26.61 M-15.56%
2017-12-31ยฃ31.51 M-12.78%
2016-12-31ยฃ36.13 M214.89%
2015-12-31ยฃ11.47 M-54.73%
2014-12-31ยฃ25.34 M41.22%
2013-12-31ยฃ17.94 M-29.97%
2012-12-31ยฃ25.62 M-52.79%
2011-12-31ยฃ54.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ44.99 B 836,332.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ44.20 B 821,578.64%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ8.76 B 162,781.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ48.83 B 907,689.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ3.22 B 59,872.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ55.76 M 936.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ58.92 B 1,095,257.86%๐Ÿ‡บ๐Ÿ‡ธ USA